Inventor · Los Angeles, CA, US

Mary Faris

104Patents
15h-index
32Co-inventors
86Inventor score

Filing activity: Jul 12, 2000 → Feb 13, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US7507541B2 36P6D5: secreted tumor antigen Emerging Cross-Sectional Technologies 77 Active
US7361338B2 Methods to inhibit growth of prostate cancer cells Chemistry; Metallurgy 33 Expired
US7037667B1 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer Physics 33 Expired
US7494646B2 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins Chemistry; Metallurgy 32 Expired
US7628989B2 Methods of inducing an immune response Human Necessities 22 Expired
US7641905B2 Methods of inducing an immune response Human Necessities 22 Expired
US6673545B2 Prostate cancer markers Chemistry; Metallurgy 22 Expired
US8008442B2 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins Chemistry; Metallurgy 19 Expired
US7947276B2 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins Chemistry; Metallurgy 17 Active
US7939503B2 Reduction of cell-cell communication in prostate cancer using STEAP-1 siRNA Chemistry; Metallurgy 16 Active
US7884179B2 Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer Chemistry; Metallurgy 16 Active
US7459539B2 Antibody that binds zinc transporter protein 108P5H8 Emerging Cross-Sectional Technologies 16 Expired
US8013135B2 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins Chemistry; Metallurgy 16 Active
US7947459B2 Serpentine transmembrane antigens expressed in human cancers and uses thereof Physics 15 Active
US7968090B2 Nucleic acids and corresponding proteins entitled 191P4D12(b) useful in treatment and detection of cancer Emerging Cross-Sectional Technologies 15 Active
US7510840B1 Method of inhibiting growth or survival of a cell by providing an anti-108P5H8 antibody Emerging Cross-Sectional Technologies 14 Expired
US7067130B2 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer Emerging Cross-Sectional Technologies 13 Expired
US7226594B2 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer Emerging Cross-Sectional Technologies 13 Expired
US7405290B2 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer Emerging Cross-Sectional Technologies 12 Expired
US7223542B2 36P6D5: secreted tumor antigen Emerging Cross-Sectional Technologies 12 Expired
US7622569B2 Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer Chemistry; Metallurgy 11 Active
US6566078B1 36P6D5: secreted tumor antigen Emerging Cross-Sectional Technologies 11 Expired
US9493454B2 Multiple kinase pathway inhibitors Human Necessities 10 Active
US8012937B2 Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer Chemistry; Metallurgy 10 Active
US7667018B2 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer Emerging Cross-Sectional Technologies 10 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.